Vaccine Development Doesn’t Stop
with Regulatory Approval

Following IRB-approved protocols, the BioIVT team works with you to enroll donors at our facilities for post-FDA approval vaccination and the collection of blood, serum or plasma, as well as non-blood derived biofluids.

These samples may be used in the development and improvement of diagnostic test kits and devices, biomarker discovery, as control specimens or as well as general disease state, clinical/medical research.

Vaccine study services provided include:

• Administration of FDA-approved vaccine (under medical supervision)
• Recruitment of patients
• Time point collections of large volume of biofluids (e.g. plasma) from subjects

To learn more about how BioIVT supports Phase IV and post FDA-approved vaccine research through our donor centers, please download our video or contact us directly.